Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Piezo1 modulates PFKFB3 during placental neovascularization in preeclampsia via YAP to regulate glycolysis in endothelial progenitor cells. | Placenta | 2026 | 41795358 | PubTator, text mining | PubMed |
| Lactylation: a metabolic-epigenetic bridge in diabetic kidney disease and a therapeutic target for TCM. | Chin Med | 2026 | 41787542 | PubTator, text mining | PubMed |
| Strategies to target PD-1/PD-L1 in the tumor microenvironment. | Cell Oncol (Dordr) | 2026 | 41784760 | PubTator, text mining | PubMed |
| Unraveling the therapeutic mechanisms of Polygonum cuspidatum in pulmonary fibrosis: Modulation of M2 macrophage polarization and glycolysis pathways. | J Ethnopharmacol | 2026 | 41780617 | PubTator, text mining | PubMed |
| Computational analysis of hub genes associated with sarcopenia: integrative transcriptome insights from an Asian cohort. | EXCLI J | 2026 | 41768858 | PubTator, text mining | PubMed |
| Role of metabolic reprogramming and lactylation in diabetic nephropathy: molecular mechanisms and therapeutic prospects - a narrative review. | Front Endocrinol (Lausanne) | 2026 | 41767381 | PubTator, text mining | PubMed |
| PFKFB3-driven glycolysis in endothelial cells activates RhoA/ROCK1 to promote pulmonary vascular leakage in heatstroke. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41763331 | PubTator, text mining | PubMed |
| LKB1-AMPK Signaling Pathway in Cardiovascular and Other Diseases. | MedComm (2020) | 2026 | 41756254 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| Quinoxaline Derivatives in Cancer Therapy: Insights into Mechanisms of Action and Therapeutic Applications. | Biomol Ther (Seoul) | 2026 | 41755772 | PubTator, text mining | PubMed |
| Novel AI-Driven Precision Strategies in Diabetic Wound Healing: Immunomodulation and Advances in Smart Composite Nanocarriers. | Pharmaceutics | 2026 | 41754993 | PubTator, text mining | PubMed |
| RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic Review. | J Clin Med | 2026 | 41753079 | PubTator, text mining | PubMed |
| When Estrogen Signaling Refuses to Die: Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers. | Int J Mol Sci | 2026 | 41752059 | PubTator, text mining | PubMed |
| Vitamin K Prophylaxis in Newborns: A Narrative Review of the Molecular Basis, Clinical Evidence, and Comparative Effectiveness of Intramuscular Versus Oral Administration and Parental Hesitation. | Int J Mol Sci | 2026 | 41751806 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| Targeting Glycolytic Metabolism in Cancer Therapy: Current Approaches and Future Perspectives. | Cells | 2026 | 41744805 | PubTator, text mining | PubMed |
| The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer. | Cell Death Discov | 2026 | 41741426 | PubTator, text mining | PubMed |
| Glycolysis in the tumor microenvironment shapes dendritic cell function and antitumor immunity. | Front Immunol | 2026 | 41737218 | PubTator, text mining | PubMed |
| Mitophagy-driven multidimensional regulation of tumor immune evasion and context-dependent therapeutic strategies. | J Transl Med | 2026 | 41736012 | PubTator, text mining | PubMed |
| Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance. | Cancer Pathog Ther | 2026 | 41732210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=5